Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma

Elisabet E. ManasanchMultiple Myeloma Section

Raul BraylanHematology Section/Department of Laboratory Medicine

Maryalice Stetler-StevensonFlow Cytometry Unit/Laboratory of Pathology

Constance YuanFlow Cytometry Unit/Laboratory of Pathology

Verena GoundenDepartment of Pathology, National Institutes of Health, Bethesda, MD, USA

Neha KordeMultiple Myeloma Section

Nishant TagejaMultiple Myeloma Section

Manisha BhutaniMultiple Myeloma Section

Katherine CalvoHematology Section/Department of Laboratory Medicine

Irina MaricHematology Section/Department of Laboratory Medicine

Mark RoschewskiMultiple Myeloma Section

Louis M. StaudtMetabolism Branch, National Cancer Institute

Ola LandgrenMultiple Myeloma SectionCorrespondence[email protected]

show all

References

Varettoni M, Arcaini L, Zibellini S, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood 2013;121:2522–2528.
PubMed Web of Science ®Google Scholar
Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012;367:826–833.
PubMed Web of Science ®Google Scholar
Korde N, Kristinsson SY, Landgren O. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood 2011;117:5573–5581.
PubMed Web of Science ®Google Scholar
Xu L, Hunter ZR, Yang G, et al. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013;121;2051–2058.
PubMed Web of Science ®Google Scholar
Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011;470:115–119.
PubMed Web of Science ®Google Scholar
Landgren O, Staudt L. MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med 2012;367:2255–2256; author reply 2256–2257.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date